Pharmaceuticals Products

Generic:

Ciprofloxacin

Therapeutic Segment:

Antibiotic

Indications:

Treatment of patients with mild to moderate infections caused by susceptible strains of the designated micro-organisms in the specific conditions listed below:

• Broncho-pulmonary infections.
• ENT infections.
• Infections of mouth, teeth and jaws.
• Uncomplicated acute cystitis.
• Complicated urinary tract infections and acute pyelonephritis.
• Bacterial prostatitis.
• Gonococcal urethritis and cervicitis.
• Gastrointestinal infections.
• Infections of the bones and joints.
• Wound and soft tissue infections.
• Peritonitis.

Available as:
Tablets:

5mg
10mg

Injections:

200mg /100ml

Generic:

Ceftriaxone sodium

Therapeutic Segment:

Antibiotic

Indications:

Treatment of infections caused by susceptible strains of the designated micro-organisms in the specific conditions listed below:

• Lower respiratory tract infections (acute bacterial bronchitis, community-acquired pneumonia, influenza and XDR typhoid fever).
• Sepsis.
• Meningitis.
• Uncomplicated acute cystitis.
• Disseminated lyme borreliosis (early and late stages of the disease).
• Abdominal infections (peritonitis, infections of the biliary and gastrointestinal tract).
• Infections of the bones, joints, soft tissues and skin.
• Infections in patients with impaired defense mechanism.
• Renal and urinary tract infections.
• Respiratory tract infections, particularly pneumonia, ear, nose and throat infections.
• Genital infections including gonorrhea.
• Pre-operative prophylaxis of infections.

Available as:

Injections:

250mg
500mg
1g
2g

Generic:

Cefepime

Therapeutic Segment:

Antibiotic

Indications:

Treatment of infections caused by susceptible strains of the designated micro-organisms in the specific conditions listed below:

• Lower respiratory tract infections including pneumonia and bronchitis.
• Urinary tract infections including pyelonephritis.
• Skin and skin structure infections.
• Intra-abdominal infections including peritonitis and biliary tract infections.
• Gynecologic infections.
• Septicemia.
• Empiric treatment in febrile neutropenia.
• Surgical prophylaxis in intra-abdominal surgeries.

Available as:

Injections:

500mg
1g

Generic:

Cefotaxime

Therapeutic Segment:

Antibiotic

Indications:

Treatment of infections caused by susceptible strains of the designated micro-organisms in the specific conditions listed below:

• Tonsillitis, pneumonia, bronchitis, bronchial extensions, secondary infections of chronic respiratory tract diseases, abscess of lung and emphysema.
• Pyelitis, urinary tract infections, gonorrhea, prostatitis, adnexitis, endometritis, infections around uterus and bartholinitis.
• Meningitis, septicemia and bacterial endocarditis.
• Osteomyelitis and septic arthritis.
• Peritonitis, cholecystitis and cholangitis.
• Prophylaxis for patients with impaired immune function.

Available as:

Injections:

250
500mg
1g

Generic:

Moxifloxacin

Therapeutic Segment:

Antibiotic

Indications:

• Acute bacterial sinusitis.
• Acute exacerbation of chronic obstructive pulmonary disease including bronchitis.
• Community-acquired pneumonia.
• Uncomplicated and complicated skin and skin structure infections.

Available as:

Tablets:

400mg

Generic:

Ofloxacin

Therapeutic Segment:

Antibiotic

Indications:

Treatment of patients with mild to moderate infections caused by susceptible strains of the designated micro-organisms in the specific conditions listed below:

• Acute bacterial exacerbations of chronic bronchitis.
• Community acquired Pneumonia.
• Uncomplicated skin and skin structure infections.
• Acute, uncomplicated urethral and cervical gonorrhea.
• Nongonococcal urethritis and cervicitis.
• Pelvic inflammatory disease.
• Uncomplicated cystitis.
• Complicated urinary tract infections and prostatitis.

Available as:

Tablets:

200mg

Generic:

Ceftriaxone

Therapeutic Segment:

Antibiotic

Indications:

Treatment of patients with mild to moderate infections caused by susceptible strains of the designated micro-organisms in the specific conditions listed below:

• Lower respiratory tract infections (acute bacterial bronchitis, community-acquired pneumonia, influenza and XDR typhoid fever).
• Sepsis.
• Meningitis.
• Disseminated lyme borreliosis (early and late stages of the disease).
• Abdominal infections (peritonitis, infections of the biliary and gastrointestinal tract).
• Infections of the bones, joints, soft tissues and skin.
• Infections in patients with impaired defense mechanism.
• Renal and urinary tract infections.
• Respiratory tract infections, particularly pneumonia, ear, nose and throat infections.
• Genital infections including gonorrhea.
• Pre-operative prophylaxis of infections

Available as:

Injections:

250mg
1g

Generic:

Levofloxacin

Therapeutic Segment:

Antibiotic

Indications:

Treatment of patients with mild to moderate infections caused by susceptible strains of the designated micro-organisms in the specific conditions listed below:

• Acute maxillary sinusitis.
• Acute exacerbation of chronic obstructive pulmonary disease including bronchitis.
• Community acquired pneumonia.
• Typhoid and paratyphoid fever.
• Complicated and uncomplicated skin and skin structure infections.
• Complicated and uncomplicated urinary tract infections.
• Acute pyelonephritis.

Available as:

Tablets:

250mg
500mg
750mg

Generic:

Meropenem

Therapeutic Segment:

Antibiotic

Indications:

• Severe pneumonia.
• Broncho-pulmonary infections in cystic fibrosis.
• Complicated urinary tract infections.
• Complicated intra-abdominal infections.
• Intra and postpartum infections.
• Complicated skin ad soft tissue infections.
• Septicemia.
• Febrile neutropenia.
• Acute bacterial meningitis.

Available as:

Injections:

500mg
1g

Generic:

Cefixime

Therapeutic Segment:

Antibiotic

Indications:

Treatment of patients with mild to moderate infections caused by susceptible strains of the designated micro-organisms in the specific conditions listed below:

• Uncomplicated urinary tract infections.
• Otitis media.
• Pharyngitis and tonsillitis.
• Acute bronchitis and acute exacerbation of chronic bronchitis.
• Uncomplicated gonorrhea (cervical/urethral).

Available as:

Capsules:

200mg 400mg

Suspensions:

100mg /5ml 200mg /5ml

Generic:

Cefoperazone + Sulbactam

Therapeutic Segment:

Antibiotic

Indications:

Treatment of infections caused by susceptible strains of the designated micro-organisms in the specific conditions listed below:

• Upper and lower respiratory tract infections.
• Upper and lower urinary tract infections.
• Peritonitis, cholecystitis, cholangitis and other intra-abdominal infections.
• Septicemia.
• Meningitis.
• Skin and soft tissue infections.
• Bone and joint infections.
• Pelvic inflammatory disease, endometritis, gonorrhea and other infections of genital tract.

Available as:

Injections:

1g
2g

Generic:

Vancomycin HCl

Therapeutic Segment:

Glycopeptide anti-biotic

Indications:

Vancotic is indicated for serious infections caused by susceptible strains of methicillin-resistant (beta-lactam-resistant) staphylococci and penicillin-allergic patients.
Vancotic is used to treat staphylococcal endocarditis, infections including septicemia, bone infections, lower respiratory tract infections, and skin & skin structure infections.

Available as:

Injections:

500mg (I.V.) – 1’s
1g (I.V.) – 1’s

Generic:

Vancomycin HCl

Therapeutic Segment:

anti-biotic

Indications:

Vinzat is indicated for the treatment of infections caused by susceptible organisms.

• Appendicitis, complicated by rupture with peritonitis and/or abscess formation in children. Because of its broad spectrum of activity, Vinzat is used for urinary tract infections, bone and joint infections, severe vaginal infections, stomach infections, skin infections, and pneumonia.

Available as:

Injections:

2.25g (I.V.) – 1’s
4.5g (I.V.) – 1’s

Generic:

Moxifloxacin

Therapeutic Segment:

Antibiotic

Indications:

• Acute bacterial sinusitis.
• Acute exacerbation of chronic obstructive pulmonary disease including bronchitis.
• Community-acquired pneumonia.
• Uncomplicated and complicated skin and skin structure infections.

Available as:

Injections:

400mg
250ml

Generic:

Linezolid

Therapeutic Segment:

Anti-biotic

Indications:

• Pneumonia.
• Community-Acquired Pneumonia.
• Skin and Skin Structure Infections.
• Methicillin-Resistant & Vancomycin-Resistant Infections.

Available as:

Tablet

400mg
600mg

Suspension

100mg
5ml

Infusion

600mg
300ml

Generic:

Azithromycin

Therapeutic Segment:

Antibiotic

Indications:

Treatment of patients with mild to moderate infections caused by susceptible strains of the designated micro-organisms in the specific conditions listed below:

• Lower respiratory tract infections (acute bacterial bronchitis, community-acquired pneumonia, influenza and XDR typhoid fever).
• Upper respiratory tract infections (acute sinusitis, acute streptococcal pharyngitis/tonsillitis and acute otitis media in children).
• Uncomplicated skin and skin structure infections and acne.
• Sexually transmitted diseases (uncomplicated urethritis and cervicitis).
• Pelvic inflammatory diseases in patients who require initial intravenous therapy.
• Chlamydial infections.

Available as:

Tablets:

250mg
500mg

Supension:

200mg / 5ml

Generic:

Ebastine

Therapeutic Segment:

Antiallergic

Indications:

• Seasonal allergic rhinitis.
• Perennial allergic rhinitis.
• Chronic idiopathic urticaria.

Available as:

Tablets:

10mg
20mg

Generic:

Montelukast

Therapeutic Segment:

Antiasthmatic

Indications:

• Prophylaxis and chronic treatment of asthma, allergic rhinitis and exercise-induced bronchoconstriction.

Available as:

Tablets:

5mg
10mg

Sachets:

4mg

Generic:

Loratadine

Therapeutic Segment:

Antiallergic

Indications:

• Allergic rhinitis.
• Chronic urticaria and other allergic dermatological disorders.

Available as:

Tablets:

10mg

Generic:

Jardin-D^®

Generic:

Desloratadine

Therapeutic Segment:

Antiallergic

Indications:

• Seasonal allergic rhinitis.
• Perennial allergic rhinitis.
• Chronic idiopathic urticaria.

Available as:

Tablets:

5mg

Syrup:

0.5mg/ml

Close

Therapeutic Segment:

Antiallergic

Indications:

• Allergic rhinitis.
• Chronic urticaria and other allergic dermatological disorders.

Available as:

Tablets:

10mg

Generic:

Empagliflozin

Therapeutic Segment:

antidiabetic

Indications:

• As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
• When diet and exercise alone do not provide adequate glycemic control in patients for whom the use of metformin is considered inappropriate due to intolerance.
• In combination with other glucose-lowering medicinal products including insulin, when these, together with diet and exercise, do not provide adequate glycemic control.

Available as:

Tablets:

10mg
25mg

Generic:

Empagliflozin + Metformin

Therapeutic Segment:

Antidiabetic

Indications:

• For the treatment of adults with type 2 diabetes mellitus as an adjunct to diet and exercise.
• In patients insufficiently controlled on their maximally tolerated dose of metformin alone.
• In combination with other medicinal products for the treatment of diabetes, in patients insufficiently controlled with metformin and these medicinal products.
• In patients already being treated with the combination of empagliflozin and metformin as separate tablets.

Available as:

Tablets:

12.5mg + 500mg
12.5mg + 850mg
12.5mg + 1000mg

Generic:

Empagliflozin + Linagliptin + Metformin HCl

Therapeutic Segment:

Antidiabetic

Indications:

• Improves glycemic control in adults with type 2 diabetes mellitus as an adjunct to diet and exercise

Available as:

Tablets:

10mg/5mg/1000mg
12.5mg/2.5mg/1000mg
25mg/5mg/1000mg

Generic:

Vildagliptin

Therapeutic Segment:

Antidiabetic

Indications:

• The treatment of type 2 diabetes mellitus in adults as monotherapy in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindication or intolerance.
• As dual oral therapy in combination with metformin, in patients with insufficient glycemic control despite a maximally tolerated dose of monotherapy with metformin.
• As triple oral therapy in combination with sulfonylureas and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycemic control.
• Also indicated for use in combination with insulin (with or without metformin) when diet and exercise plus a stable dose of insulin do not provide adequate glycemic control.

Available as:

Tablets:

50mg

Generic:

Vildagliptin + Metformin

Therapeutic Segment:

Antidiabetic

Indications:

• For the treatment of adults with type 2 diabetes mellitus as an adjunct to diet and exercise.
• In patients whose diabetes is not adequately controlled on metformin or vildagliptin as separate tablets.

Available as:

Tablets:

50mg + 500mg
50mg + 850mg
50mg + 1000mg

Generic:

Glimepiride

Therapeutic Segment:

Antidiabetic

Indications:

• As an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes whose diabetes is not adequately controlled by diet and exercise alone.

Available as:

Tablets:

1mg
2mg
3mg
4mg

Generic:

Glimepiride + Metformin

Therapeutic Segment:

Antidiabetic

Indications:

• Pre-operative prophylaxis of infections

Available as:

Tablets:

2mg + 500mg

Generic:

Iron Sucrose

Therapeutic Segment:

Hematinic

Indications:

• For the treatment of iron deficiency anemia in patients with chronic kidney disease (CKD).
• Iron deficiency because of other reasons (before and after surgery, final stages of pregnancy, intolerance, non-responsiveness or non-compliance to oral iron therapy, malabsorption etc).

Available as:

Injections:

100mg/5ml

Generic:

Iron (III) Hydroxide Polymaltose Complex

Therapeutic Segment:

Hematinic

Indications:

For the prevention and treatment of iron deficiency anemia:

• During pregnancy and lactation.
• In children, adolescents, women of childbearing age and adults.

Available as:

Chewable Tablets:

100mg

Syrup:

50mg/5ml

Generic:

Iron (III) Hydroxide Polymaltose Complex + Folic Acid

Therapeutic Segment:

Antianemic

Indications:

• For the treatment of latent and manifest iron deficiency anemia.
• To prevent iron and folic acid deficiency before, during and after pregnancy (during lactation).

Available as:

Chewable Tablets:

100mg + 0.35mg

Generic:

Letrozole

Therapeutic Segment:

Aromatase Inhibitor

Indications:

• For the treatment of all stages of hormone receptor-positive breast cancer in postmenopausal women.

Available as:

Tablets:

2.5mg

Generic:

Artemether + Lumefantrine

Therapeutic Segment:

Antimalarial

Indications:

• Treatment of adults and children with acute, uncomplicated infections due to plasmodium falciparum, including malarial infections acquired in areas where the parasites may be resistant to other anti-malarials.

Available as:

Tablets:

20mg + 120mg
40mg + 240mg
80mg + 480mg

Generic:

Artemether

Therapeutic Segment:

Antimalarial

Indications:

• Treatment of all kinds of malaria, including chloroquine-resistant malaria and first aid for fatal malaria.

Available as:

Injections:

80mg

Generic:

Fluconazole

Therapeutic Segment:

Antifungal

Indications:

• Acute or recurrent vaginal candidiasis.
• Mucosal candidiasis e.g oropharyngeal, oesophageal, bronchopulmonary, mucocutaneous & denture sore mouth.
• Athlete’s foot (Tinea pedis), ringworm (Tinea corporis), Tinea cruris, Tinea versicolor & dermal candida infection.
• Cryptococcosis, Cryptococcal meningitis and infections of other sites (pulmonary & cutaneous).
• Prevention of fungal infection in immunocompromised patients.

Available as:

Capsule:

150mg

Generic:

Rosuvastatin

Therapeutic Segment:

Antihyperlipidemic

Indications:

• Management of hypercholesterolemia, mixed dyslipidemia, hypertriglyceridemia (HTG) and homozygous familial hypercholesterolemia.

Available as:

Tablets:

5mg
10mg
20mg

Generic:

Atorvastatin

Therapeutic Segment:

Antihyperlipidemic

Indications:

• Management of hypercholesterolemia, mixed dyslipidemia, hypertriglyceridemia (HTG) and homozygous familial hypercholesterolemia.

Available as:

Tablets:

10mg
20mg
40mg

Generic:

Losartan potassium

Therapeutic Segment:

Antihypertensive

Indications:

• Hypertension.
• Ventricular hypertrophy.
• Ventricular hypertrophy.
• Diabetic neuropathy with an elevated serum creatinine and proteinuria in type 2 diabetic patients.

Available as:

Tablets:

25mg
50mg

Generic:

Losartan potassium + Hydrochlorothiazide

Therapeutic Segment:

Antihypertensive

Indications:

• Hypertension.
• Ventricular hypertrophy.

Available as:

Tablets:

50mg + 12.5mg

Generic:

Amlodipine

Therapeutic Segment:

Antihypertensive

Indications:

• Hypertension.
• Prophylaxis of chronic stable angina pectoris.
• Confirmed or suspected vasospastic angina.

Available as:

Tablets:

5mg
10mg

Generic:

Clopidogrel

Therapeutic Segment:

Platelet Aggregation Inhibitor

Indications:

• It is indicated for the reduction of thrombotic events in patients with recent myocardial infarction, acute coronary syndrome, recent stroke or established peripheral arterial disease.

Available as:

Tablets:

75mg (14’s)

Generic:

Cholecalciferol

Therapeutic Segment:

Vitamin and Vitamin Analogue

Indications:

• For the prevention and treatment of vitamin D deficiency.
• Recommended in rickets due to vitamin D resistance.

Available as:

Injections:

5mg (200,000 IU) /ml

Generic:

Omeprazole

Therapeutic Segment:

Antiulcerant

Indications:

• Gastroesophageal reflux disease (GERD).
• Gastric and duodenal ulcers.
• Treatment and prophylaxis of NSAID-associated ulceration.
• Eradication of H.pylori infection associated with peptic ulcer disease.
• Zollinger-Ellison syndrome.
• Dyspepsia.
• Prophylaxis of acid aspiration.

Available as:

Capsules:

20mg
40mg

Infusion:

40mg

Generic:

Omeprazole + Sodium Bicarbonate

Therapeutic Segment:

Antiulcerant

Indications:

• Treatment of gastroesophageal reflux disease (GERD), heartburn and other symptoms associated with GERD and treatment of erosive esophagitis (EE) which has been diagnosed by endoscopy.
• Short-term treatment of active duodenal ulcer.
• Treatment and prophylaxis of NSAID-associated ulceration.
• Short-term treatment of active benign gastric ulcer.
• Maintenance treatment of healing of erosive esophagitis (EE).
• Reduction treatment of risk of upper gastrointestinal bleeding in critically ill patients.

Available as:

Sachet:

40mg + 1680mg

Generic:

Esomeprazole

Therapeutic Segment:

Antiulcerant

Indications:

• Gastroesophageal reflux disease (GERD) & symptomatic GERD without esophagitis.
• Erosive esophagitis (EE), long-term management of patients with healed esophagitis to prevent relapse.
• H. pylori eradication to reduce the risk of duodenal ulcer.
• Short-term treatment of gastroesophageal reflux disease (GERD) with erosive esophagitis (EE) in adults and pediatric patients 1 month to 17 years of age, as an alternative to oral therapy when oral esomeprazole is not possible or appropriate.
• Risk reduction of re-bleeding of gastric or duodenal ulcers following therapeutic endoscopy for acute bleeding of gastric or duodenal ulcers in adults.

Available as:

Capsules:

20mg
40mg

Injections:

40mg

Generic:

Levosulpiride

Therapeutic Segment:

Gastroprokinetic

Indications:

• Gastroesophageal reflux disease (GERD).
• Irritable bowel syndrome.
• Dyspeptic syndrome due to delayed gastric emptying.
• Vertigo.
• Schizophrenia.

Available as:

Tablets:

25mg
50mg

Generic:

Itopride Hydrochloride

Therapeutic Segment:

Gastroprokinetic

Indications:

• Functional dyspepsia.
• Non-ulcer dyspepsia (chronic gastritis).ally ill patients.

Available as:

Tablets:

50mg

Generic:

Famotidine

Therapeutic Segment:

Antiulcerant

Indications:

• Duodenal ulcers.
• Prevention of recurrence of duodenal ulcers.
• Benign gastric ulcer.
• Gastroesophageal reflux.
• Hypersecretory conditions such as Zollinger-Ellison syndrome.

Available as:

Tablets:

20mg
40mg

Generic:

Domperidone

Therapeutic Segment:

Gastroprokinetic

Indications:

• Dyspeptic symptom complex that is often associated with delayed gastric emptying, gastroesophageal reflux and esophagitis.
• Prevention and treatment of nausea and vomiting.

Available as:

Tablets:

10mg

Generic:

Tamsulosin HCI

Therapeutic Segment:

Urology

Indications:

• The treatment of the signs and symptoms of benign prostatic hyperplasia (BPH).

Available as:

Capsules:

0.4mg

Generic:

Tramadol HCl + Paracetamol

Therapeutic Segment:

Analgesic

Indications:

• Management of moderate to severe painful conditions.

Available as:

Tablets:

37.5mg
325mg

Generic:

Piroxicam-β-cyclodextrin

Therapeutic Segment:

Analgesic

Indications:

• A variety of acute painful conditions requiring anti-inflammatory and analgesic activity, including rheumatoid arthritis, osteo-arthritis (arthrosis, degenerative joint disease), ankylosing spondylitis, musculoskeletal and joint disorders, gout, in soft-tissue disorders and in post-operative pain.

Available as:

Tablets:

20mg

Generic:

Diclofenac Sodium

Therapeutic Segment:

Analgesics

Indications:

• For the treatment of rheumatoid arthritis, ankylosing spondylitis, osteoarthritis, low back pain, frozen shoulder, tendinitis, tenosynovitis, bursitis, strains, sprains & acute gout.
• To control the pain and inflammation in orthopedic, dental and minor surgeries.
• In children, for the treatment of juvenile chronic arthritis.

Available as:

Tablets:

50mg
100mg

Generic:

Tizanidine

Therapeutic Segment:

Muscle Relaxant

Indications:

• Treatment of painful muscle spasms.
• Treatment of spasticity due to neurological disorders.

Available as:

Tablets:

2mg
4mg